Nihal Martis
@nihalm_nice
Internist... Sometimes intensivist, mostly clinician, in the South of France. MCU-PH.
ID: 2920062394
13-12-2014 18:00:31
936 Tweet
252 Followers
673 Following
NEW for #LUPUS2025—ERN ReCONNET 🇪🇺–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic #lupus erythematosus manifestations bit.ly/3YXEmAO Free to read with registration on lancet.com (also free) Laurent ARNAUD #SLE
Thank you The Lancet Rheumatology for the opportunity to discuss the current evidence towards #Precision medicine in #Antiphospholipid syndrome, a rare disorder with therapeutic unmet needs.
Just out! New IMS/ IMWG Definition of High Risk Myeloma. Journal of Clinical Oncology #IMWG25 Myeloma Society International Myeloma Foundation Nikhil C. Munshi, MD marivi mateos Sagar Lonial MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Noopur Raje
Nerandomilast: the new & improved nintedanib. Does it work for our rheum pts? Autoimmune subgroup of FIBRONEER-ILD (NEJM last month) - mortality benefit vs placebo (this is new) - well tolerated (minimal increase in diarrhoea vs placebo) One to watch #EULAR2025 LB0003 Dr. John Cush
Very informative presentation by DrJE-Salem ⚠️ don't hurry up with antiarrhythmic therapy in ICI induced severe arrythmias and be aware of increased risk for developing of high grade conduction disorders #ESCardioOnc2025 #cardiooncology
Bravo à Thibault Comont, MD et collaborateurs !
Peter’s Pearls in vasculitis - Dr Merkel noted: 1. Do NOT follow ANCA titers 2. Anti-PR3 ANCA more likely to relapse 3. ANCA+ EGPA behaves like GPA/MPA 4. Don’t delay is there is Pulm hemorrhage/ RPGN 5. Steroids save lives in the short term #CCRwest Dr. John Cush
🫁New in #CritCare This physiological study compares driving pressure-based vs. oxygenation-based PEEP strategies. Clinical PEEP titration showed better respiratory mechanics and lower lung stress—especially in moderate-severe ARDS. 🔗ccforum.biomedcentral.com/articles/10.11… Jean-Louis Vincent
Il parait qu'il n'y a pas d'argent dans les caisses. L'assurance maladie refuse toujours la prise en charge de marqueurs tumoraux indispensables pour des patients. mais AUCUN PROBLÈME à financer des fakemeds. Marguerite C. : c'est la fête dans les CPAM ?
Excited to have led this initiative and grateful for all centres' contributions to a multiethnic study of 1001 patients with #APS, underlining the need for #cardiovascular risk management in primary APS and #SLE/APS. The Lancet Rheumatology thelancet.com/journals/lanrh…